Forms Comparison
| Form | Bioavailability | Best For |
|---|---|---|
| Standard Boswellia Extract (65% boswellic acids) | Moderate | General anti-inflammatory use — widely available and well-studied |
| Aflapin (enriched extract) | High | Faster onset — shows effects within 5-7 days in clinical trials at 100mg/day |
| 5-Loxin (30% AKBA) | High | Targeted 5-LOX inhibition — concentrated AKBA for maximum enzyme inhibition |